Metraipolis › archive › dc_e39eb185dfc3
Bispecific Antibody and Antibody-Drug Conjugate as Novel Candidates for Treating Pancreatic Ductal Adenocarcinoma — Europe PMC PMID:41154706
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41154706
- DOI
- 10.3390/biom15101477
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T04:54:19.047Z
- SHA-256 of the archived text
7dcaa4ac85d18333b2d6ca34ede489c1c6cd6c995a178544f0ef6ea6c792b735- Stable URL of this page
https://metraipolis.com/documento/dc_e39eb185dfc3
How to cite
Bispecific Antibody and Antibody-Drug Conjugate as Novel Candidates for Treating Pancreatic Ductal Adenocarcinoma — Europe PMC PMID:41154706 — Europe PMC (en), https://europepmc.org/article/MED/41154706 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e39eb185dfc3 (Metraipolis archive dc_e39eb185dfc3, sha256 7dcaa4ac85d18333b2d6ca34ede489c1c6cd6c995a178544f0ef6ea6c792b735)
BibTeX
@misc{dce39eb185dfc3,
title = {Bispecific Antibody and Antibody-Drug Conjugate as Novel Candidates for Treating Pancreatic Ductal Adenocarcinoma — Europe PMC PMID:41154706},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41154706},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e39eb185dfc3; sha256 7dcaa4ac85d18333b2d6ca34ede489c1c6cd6c995a178544f0ef6ea6c792b735},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41154706. Agents can read the archived copy with the MCP tool read_document.